Expressão do antígeno CD83 e o seu papel na progressão de neoplasias sistêmicas

Borges MN, Facina G, Silva ID, Waitzberg AF, Nazario AC. Analysis of CD83 antigen expression in human breast fibroadenoma and adjacent tissue. Sao Paulo Med J. 2011;129(6):402-9.

Ananiev J, Gulubova MV, Manolova IM. Prognostic significance of CD83 positive tumor-infiltrating dendritic cells and expression of TGF-beta 1 in human gastric cancer. Hepatogastroenterology. 2011;58(110-111):1834-40.

Kashimura S, Saze Z, Terashima M, et al. CD83(+) dendritic cells and Foxp3(+) regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer. Gastric Cancer. 2012;15(2):144-53.

Furihata M, Ono Y, Ichikawa K, et al. Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma. Oncol Rep. 2005;14(2):353-6.

Iwamoto M, Shinohara H, Miyamoto A, et al. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer. 2003;104(1):92-7.

Yu KJ, Rader JS, Borecki I, Zhang Z, Hildesheim A. CD83 polymorphisms and cervical cancer risk. Gynecol Oncol. 2009;114(2):319-22.

Hock BD, Fernyhough LJ, Gough SM, et al. Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia. Leuk Res. 2009;33(8):1089-95.

Gao C, Zhong WX, Zheng SD, et al. [Preparation and characterization of a novel functional anti-human CD83 monoclonal antibody]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009;25(100):914-6.